MESOBLAST LTD.

In News

Mesoblast (MESO) CEO Silviu Itescu reports major share and option holdings - Stock Titan

Stock Titan - Apr 01, 2026

Mesoblast Limited (ASX:MSB): Are Analysts Optimistic? - finance.yahoo.com

finance.yahoo.com - Nov 11, 2025

Mesoblast reports $US35.1m in gross revenue from sales of its cell therapy Ryoncil - Proactive financial news

Proactive financial news - Jan 08, 2026

Earnings call transcript: Mesoblast’s strong Q1 2026 performance boosts outlook - Investing.com

Investing.com - Feb 26, 2026

Mesoblast Ltd expected to post a loss of 7 cents a share - Earnings Preview - TradingView

TradingView - Feb 25, 2026

Mesoblast (NASDAQ: MESO) plans April 8 New York R&D Day event - Stock Titan

Stock Titan - Mar 18, 2026

Is Mesoblast's New Clinical Leader Quietly Reframing Its Commercialization Story for Cell Therapies (ASX:MSB)? - simplywall.st

simplywall.st - Mar 14, 2026

Mesoblast (MESO) Reports Significant Miss in 1H Earnings - GuruFocus

GuruFocus - Feb 27, 2026

Mesoblast (MESO) Sees Optimism From Analysts - finance.yahoo.com

finance.yahoo.com - Dec 15, 2025

Mesoblast to meet FDA on opioid reduction data from Rexlemestrocel-L Phase 3 trial - Proactive financial news

Proactive financial news - Nov 04, 2025

Mesoblast (MESO) director George Gregory details share, warrant and option holdings - Stock Titan

Stock Titan - Mar 23, 2026

Inside Biotech: Mesoblast slips as FDA feedback meets market reality - Proactive financial news

Proactive financial news - Jan 18, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment